Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, is featured in a study with the European Lung Cancer Congress, Characteristics of Long-Term Survivors in the CASPIAN study.
“There were >3 times as many LTS in the D+EP arm vs the EP arm. LTS were more likely to have favourable prognostic characteristics than ITT, although some LTS had brain/liver mets at baseline. Notably, most LTS completed EP induction and, in both the IO+EP arms, had substantially greater overall treatment exposure, as well as achieving higher ORR and longer PFS, vs ITT. There was no evidence of cumulative toxicity based on SAEs.Table: 141O” To read the abstract, click here
Founded in 1979, CHCWM has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families. Thanks to the hard work of our growing staff, CHCWM has been named one of the Nation’s Best and Brightest Companies to Work For®. To learn more about CHCWM, visit chcwm.com.
Contact Information
Becky Byers
Marketing Coordinator, [email protected]